Tags

Type your tag names separated by a space and hit enter

Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.
J Neurochem. 2010 Apr; 113(1):67-78.JN

Abstract

3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') produces selective long-lasting serotonergic neurotoxicity in rats. The drug also produces acute hyperthermia which modulates the severity of the neurotoxic response. In addition, MDMA produces signs of neuroinflammation reflected as microglial activation and an increase in the release of interleukin-1beta, the latter of which appears to be a consequence of the hyperthermic response and to be implicated in the neurotoxicity induced by the drug. Over-expression of the cannabinoid CB2 receptor in microglia during non-immune and immune pathological conditions is thought to be aimed at controlling the production of neurotoxic factors such as proinflammatory cytokines. Our objective was to study the pattern of CB2 receptor expression following MDMA and to examine the effect of JWH-015 (a CB2 agonist) on the MDMA-induced neuroinflammatory response as well as 5-hydroxytryptamine (5-HT) neurotoxicity. Adult Dark Agouti rats were given MDMA (12.5 mg/kg, i.p.) and killed 3 h or 24 h later for the determination of CB2 receptor expression. JWH-015 was given 48 h, 24 h and 0.5 h before MDMA and 1 h and/or 6 h later and animals were killed for the determination of microglial activation (3 h and 24 h) and 5-HT neurotoxicity (7 days). MDMA increased CB2 receptor expression shortly after administration and these receptors were found in microglia. JWH-015 decreased MDMA-induced microglial activation and interleukin-1beta release and slightly decreased MDMA-induced 5-HT neurotoxicity. In conclusion, CB2 receptor activation reduces the neuroinflammatory response following MDMA and provides partial neuroprotection against the drug.

Authors+Show Affiliations

Departamento de Farmacologia, Facultad de Medicina, Universidad Complutense, Madrid, Spain.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

20067581

Citation

Torres, Elisa, et al. "Evidence That MDMA ('ecstasy') Increases Cannabinoid CB2 Receptor Expression in Microglial Cells: Role in the Neuroinflammatory Response in Rat Brain." Journal of Neurochemistry, vol. 113, no. 1, 2010, pp. 67-78.
Torres E, Gutierrez-Lopez MD, Borcel E, et al. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain. J Neurochem. 2010;113(1):67-78.
Torres, E., Gutierrez-Lopez, M. D., Borcel, E., Peraile, I., Mayado, A., O'Shea, E., & Colado, M. I. (2010). Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain. Journal of Neurochemistry, 113(1), 67-78. https://doi.org/10.1111/j.1471-4159.2010.06578.x
Torres E, et al. Evidence That MDMA ('ecstasy') Increases Cannabinoid CB2 Receptor Expression in Microglial Cells: Role in the Neuroinflammatory Response in Rat Brain. J Neurochem. 2010;113(1):67-78. PubMed PMID: 20067581.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain. AU - Torres,Elisa, AU - Gutierrez-Lopez,Maria Dolores, AU - Borcel,Erika, AU - Peraile,Ines, AU - Mayado,Andrea, AU - O'Shea,Esther, AU - Colado,Maria Isabel, Y1 - 2010/01/12/ PY - 2010/1/14/entrez PY - 2010/1/14/pubmed PY - 2010/5/1/medline SP - 67 EP - 78 JF - Journal of neurochemistry JO - J. Neurochem. VL - 113 IS - 1 N2 - 3,4-Methylenedioxymethamphetamine (MDMA, 'ecstasy') produces selective long-lasting serotonergic neurotoxicity in rats. The drug also produces acute hyperthermia which modulates the severity of the neurotoxic response. In addition, MDMA produces signs of neuroinflammation reflected as microglial activation and an increase in the release of interleukin-1beta, the latter of which appears to be a consequence of the hyperthermic response and to be implicated in the neurotoxicity induced by the drug. Over-expression of the cannabinoid CB2 receptor in microglia during non-immune and immune pathological conditions is thought to be aimed at controlling the production of neurotoxic factors such as proinflammatory cytokines. Our objective was to study the pattern of CB2 receptor expression following MDMA and to examine the effect of JWH-015 (a CB2 agonist) on the MDMA-induced neuroinflammatory response as well as 5-hydroxytryptamine (5-HT) neurotoxicity. Adult Dark Agouti rats were given MDMA (12.5 mg/kg, i.p.) and killed 3 h or 24 h later for the determination of CB2 receptor expression. JWH-015 was given 48 h, 24 h and 0.5 h before MDMA and 1 h and/or 6 h later and animals were killed for the determination of microglial activation (3 h and 24 h) and 5-HT neurotoxicity (7 days). MDMA increased CB2 receptor expression shortly after administration and these receptors were found in microglia. JWH-015 decreased MDMA-induced microglial activation and interleukin-1beta release and slightly decreased MDMA-induced 5-HT neurotoxicity. In conclusion, CB2 receptor activation reduces the neuroinflammatory response following MDMA and provides partial neuroprotection against the drug. SN - 1471-4159 UR - https://www.unboundmedicine.com/medline/citation/20067581/Evidence_that_MDMA__'ecstasy'__increases_cannabinoid_CB2_receptor_expression_in_microglial_cells:_role_in_the_neuroinflammatory_response_in_rat_brain_ L2 - https://doi.org/10.1111/j.1471-4159.2010.06578.x DB - PRIME DP - Unbound Medicine ER -